Resources

Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C

Showing 21 to 30 of 409 resources

  • Laboratory reports of hepatitis C in England and Wales, 2019
    This report from Public Health England reveals that there were 16,005 confirmed laboratory reports of hepatitis C in England and Wales during 2019. The demographic breakdown of individuals with reported hepatitis C per quarter was relatively consistent with more reports among males and in the 35 to 44 year old age group. Overall, there was a 2.9% decrease in the number of reports received during 2019 compared to 2018.
    England, Wales 15 Jun 2021 Reports & Research PDF
  • Webinar: Hepatitis C Outreach
    Outreach hepatitis C care, including ‘pop-up’ clinics, as well as the use of testing vans, is a crucial aspect of the hepatitis C elimination programme. Such outreach work, which does not rely on static services to deliver care, can be an important way to reach people who are the most under-served by these services. This webinar covered the importance of outreach, as well as specific good practice examples, such as van-based outreach work, pop-up testing during the Covid-19 pandemic and Point of Care Test and Treat outreach in the West Midlands.
    UK, England 25 May 2021 Case study, Strategy & Planning Video
  • Drugs: Policy and Aims - A Manifesto for Scotland
    This document from the Scottish Drugs Forum sets out a 'manifesto' for the group's view on the approach the next Scottish Government should take towards drug policy and tackling Scotland's drugs deaths crisis. Among the recommended steps are that the Government invest in HIV and hepatitis testing for all people who may be at risk through drug use, or who have a history of drug use.
    Scotland 22 Apr 2021 Reports & Research, Tools & Templates, Strategy & Planning PDF
  • Summary report: Hepatitis C service recovery in England webinar
    This summary reports features key points from the contributions at the 26th March 2021 HCV Action webinar looking at hepatitis C service recovery in England. Speakers at the webinar included: Prof Graham Foster, National Clinical Lead for ODNs, NHS England; Mark Gillyon-Powell, Head of Programme – HCV Elimination, NHS England/NHS Improvement; Stacey Smith, Director of Nursing, Humankind; Colin Lawton, Northern Regional Prison Lead, The Hepatitis C Trust; and Julia Sheehan, Women’s Prisons Peer Coordinator, The Hepatitis C Trust.
    England 12 Apr 2021 Reports & Research, Strategy & Planning PDF
  • Good practice case study video: The Hepatitis C Trust's 'Follow Me' programme
    In this good practice case study video, taken from HCV Action's 'Hepatitis C service recovery in England' webinar on 26th March 2021, Colin Lawton and Julia Sheehan from The Hepatitis C Trust outline the impact of the charity's prison-to-community 'Follow Me' programme.
    UK, England 09 Apr 2021 Case study Video
  • Webinar: Hepatitis C service recovery in England
    This HCV Action webinar, which took place on 26th March 2021, examined how hepatitis C services have been maintained in England during the COVID-19 pandemic and looked at plans to expand service provision over the next few months. Speakers: - Prof Graham Foster, National Clinical Lead for ODNs, NHS England - Mark Gillyon-Powell, Head of Programme – HCV Elimination, NHS England/NHS Improvement - Stacey Smith, Director of Nursing, Humankind - Colin Lawton, Northern Regional Prison Lead, The Hepatitis C Trust - Julia Sheehan, Women’s Prisons Peer Coordinator, The Hepatitis C Trust
    England 29 Mar 2021 Training, Strategy & Planning Video
  • Shooting Up: infections among people who inject drugs in the UK, 2019
    Drug use in the United Kingdom is among the highest reported in Western Europe and people who inject drugs (PWID) experience stark health inequalities, with increased morbidity and early mortality. This report explores infections, as well as associated risks and behaviours, among people who inject drugs in the UK to the end of 2019. It also presents preliminary data on the impact of COVID-19 on PWID and services in 2020.
    UK, England, Northern Ireland, Scotland, Wales 28 Jan 2021 Reports & Research PDF
  • Northern Ireland Hepatitis C Elimination Plan
    This Northern Ireland Department of Health and Public Health Agency action plan sets out the approach to eliminating hepatitis C in Northern Ireland by 2025, five years ahead of the World Health Organization 2030 target.
    Northern Ireland 20 Jan 2021 Reports & Research, Strategy & Planning PDF
  • Cost-effectiveness of opt-out HCV and HBV testing in A&E in the UK
    Research published in Value in Health in December 2020 found that testing for hepatitis C and hepatitis B in A&E departments in the UK is highly likely to be cost effective due to high rates of hepatitis among people who attend A&E. Based on a study of two London hospitals, the paper argues that, just as NICE guidelines recommend testing people attending A&E for HIV, hepatitis C and hepatitis B testing should also occur.
    UK 22 Dec 2020 Reports & Research PDF
  • The impact of the COVID-19 pandemic on prevention, testing, diagnosis and care for sexually transmitted infections, HIV and viral hepatitis in England
    This Public Health England report covers the findings of analyses of the impact of the COVID-19 pandemic response on sexually transmitted infection (STI), HIV and viral hepatitis service provision and epidemiology. Despite a resurgence in hepatitis C testing and treatment initiations from June 2020, testing and treatment initiations in the summer of 2020 were considerably lower than in corresponding months in 2019. The report notes that "HCV testing through traditional venues may not have reached those in greatest need", describing this is "of particular concern".
    England 17 Dec 2020 Reports & Research PDF

Pages